Slide Stainer Market Size & Share Report, 2032
Slide Stainer Market Size, Share Global Analysis Report, 2023-2032

Slide Stainer Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents, Equipment, and Consumables & Accessories); By Technology; By Application; By Region; Segment Forecast, 2023 - 2032

  • Published Date:Jul-2023
  • Pages: 114
  • Format: PDF
  • Report ID: PM3490
  • Base Year: 2022
  • Historical Data: 2019-2021

Report Outlook

The global slide stainer market was valued at USD 4.37 billion in 2022 and is expected to grow at a CAGR of 6.4% during the forecast period.Rising need and demand for the product form various diagnostic centers and hospitals around the world and growing penetration for automation of the laboratories and major research centers coupled with the growing technological advancements and innovations in the products features and capabilities, are among the major factors expected to boost the demand and growth of the market.

Slide Stainer Market Size

To Understand More About this Research: Request a Free Sample Report

In addition, the increasing number of slide staining procedures globally, as it helps in the identification of specific cells, organs, and tissues and high prevalence in oncology research, are further anticipated to create lucrative growth opportunities for the market over the coming years. For instance, in May 2022, Leica Biosystems, introduced BOND-PRIME, a staining solution to boost lab productivity. It is only available system which enables technicians to load slides in with any time of reagent.

Moreover, governments and private organizations are investing heavily in healthcare infrastructure especially in the emerging economies such as India, China, Malaysia and India, which drives the adoption of new medical technologies including slide stainers in hospitals and diagnostic centers. The increasing focus of the product on research in life sciences as they are an essential tool for processing and staining tissue samples in laboratories, is also generating huge potential for market growth.

However, the lack of skilled professionals for better slide staining work, product recalls, and easy availability of alternative refurbished equipment to slide strainers, are key factors projected to hinder the growth of the global market in the near future.

The outbreak of the COVID-19 pandemic has positively impacted the growth of the slide Stainer market. With the extensive rise in the number of COVID-19 cases across the globe, the need and demand for various medical supplies were drastically increasing both from healthcare professionals and civil population for the precautionary measures. Manufacturers of these supplies were focused on meeting the continuous need and supply of personal protective equipment during the pandemic.

 Slide Stainer Market Share, Size

For Specific Research Requirements,  Request for a Customized Report

Industry Dynamics

Growth Drivers
The high volume of slide staining places at higher demand for improved slide stainer products and growing prevalence of cancer, chronic, and infectious diseases coupled with the incorporation of fast, efficient, and high throughput features of semi-automated and automated systems, in order to meet the rising demand across both developed and developing economies, which are the major factors propelling the growth of the market.

Furthermore, the emerging trend towards the personalized medicine, which has led to the development of slide stainer that can be easily programmed to perform various specific staining procedures according to individual patient needs and growing focus on environmentally friendly in the healthcare sector, is further propelling the growth of the market.

Report Segmentation

The market is primarily segmented based on product, technology, application, and region.

By Product

By Application

By End-Use

By Region

  • Reagents
  • Equipment
  • Consumables & Accessories
  • Hematoxylin and Eosin
  • Immunohistochemistry
  • Cytology
  • Microbiology
  • Special Stains
  • In-situ Hybridization
  • Hematology
  • Diseases Diagnosis
  • Medical Research
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

Reagents segment is expected to witness highest growth over the forecast period

The reagents segment is projected to grow at fastest CAGR during the anticipated period, which is mainly driven by rapidly growing incidence of various types of chronic, infectious, and acute diseases across the globe and growth in the clinical research & development activities coupled with the surging penetration for laboratory automation solutions. In addition, the extensive rise in the government spending on the development of healthcare infrastructure across both developed and developing nations with increasing people spending capacity, are likely to have positive impact on the segment market growth.

The consumables & accessories segment is further anticipated to register significant growth rate and will account for decent market share over the coming years. The increasing demand for slide stainer for clinical diagnosis and research purposes around the world, has led to significant adoption and demand of the segment market. As more labs and healthcare facilities are looking to adopt automated slide staining, the need for consumables and accessories is likely to gain huge traction and growth.

Hematoxylin & eosin segment accounted for the largest market share in 2022

The growth of the segment can be highly accelerated to increasing use H&E staining technique in histology and pathology laboratories for the diagnosis of various types of diseases. Additionally, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes is resulting in a higher demand for histology and pathology diagnostics, which in turn is driving the growth of the H&E segment over the coming years.

The immunohistochemistry segment is expected to grow at significant growth rate over the projected period. The rapid development of advanced and more innovated slide stainer that can perform multiple staining procedures simultaneously with improved accuracy coupled with the growing use of immunohistochemistry for research & development activities of drug discovery, are key factors fueling the growth of the segment soon.

Disease diagnosis segment held the significant market share in 2022

The disease diagnosis segment held the significant market revenue share in 2022, which is highly attributable to rapid increase in the number of incidences of several types of cancer such as breast cancer, gastric cancer, lymphoma, and many others and continuously rising prevalence of various infections around the world. In addition, slide stainer are being widely used in pathology labs to prepare tissue samples for examination under a microscope which is an essential step in disease diagnosis, thereby propelling the segment growth.

The medical research segment is expected to grow at substantial growth rate over the coming years, mainly due to the growing need and demand for high-quality research tools in the medical research industry and rapidly increasing prevalence of advanced and innovated slide strainers, which offers automated staining, high-throughput capacity, and digital imaging capabilities.

North America region dominated the industry in 2022

North America region dominated the global market with maximum share in 2022, and is expected to maintain its dominance over the anticipated period, which is mainly attributed to presence of massive pool of geriatric population, growing prevalence of various chronic diseases and infectious and robust presence of the significantly large market players especially in countries like US and Canada. Additionally, the growing adoption of technologically enhanced laboratory equipment and increasing emphasis on laboratory automation along with the rising funding for healthcare R&D activities across the region, which in turn, propelling the regional market growth.

Asia Pacific region is anticipated to register with high growth rate during the projected period, mainly due to exponential growth in pharmaceutical and biotechnology industries and surging need for improved diagnosis of several diseases and infections. Moreover, the rising number of mergers and acquisitions in the market that help market players to expand their product portfolio and geographical presence, is pushing the market growth forward at rapid pace.

Competitive Insight

Some of the major players operating in the global market include Danaher Corporation, Roche, PHC Holdings, Agilent Technologies, Becton, Dickson, Siemens Healthineers, Biocare Medical, Hardy Diagnostics, Biogenex, SLEE Medical, Cellpath, Rockland Immunochemicals, Cell Signaling Technology, and Diagnostic BioSystems.

Recent Developments

In June 2022, Roche introduced “BenchMark ULTRA PLUS” for cancer diagnostics that enable timely and targeted patient care. It is new staining system integrated with optimized work-flow, high efficiency, & environmentally sustainable features allowing pathologists to provide quality & time-critical results to both doctors and patients.

In July 2022, CellaVision introduced its new product named “DIFF-Line, a new work-flow solution for the low-volume hematology labs. It consists three different instruments for the smearing, staining, & analyzing peripheral blood smears, that ensures high stain quality & reproducibility while reducing the exposure of staff to toxic chemicals.

Slide Stainer Market Report Scope

Report Attributes


Market size value in 2023

USD 4.64 billion

Revenue forecast in 2032

USD 8.12 billion


6.4% from 2023– 2032

Base year


Historical data

2019– 2021

Forecast period

2023– 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2032

Segments covered

By Product, By Technology, By Application, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Danaher Corporation, F. Hoffmann-La Roche Ltd., PHC Holdings, Agilent Technologies Inc., Becton, Dickson and Company, Siemens Healthineers, Biocare Medical LLC, Hardy Diagnostics, General Data Company, Biogenex, SLEE Medical GmbH, Cellpath Ltd., Rockland Immunochemicals, Cell Signaling Technology Inc., and Diagnostic BioSystems Inc.


The global slide stainer market size is expected to reach USD 8.12 billion by 2032.

Top market players in the Slide Stainer Market are Danaher Corporation, Roche, PHC Holdings, Agilent Technologies, Becton, Dickson, Siemens Healthineers.

North America contribute notably towards the global Slide Stainer Market.

The global slide stainer market expected to grow at a CAGR of 6.4% during the forecast period.

The Slide Stainer Market report covering key are product, technology, application, and region.